Results 61 to 70 of about 10,137 (203)

CARDIORENAL SYNDROME IN CHRONIC HEART FAILURE: PATHOGENESIS, DIAGNOSTICS, PROGNOSIS AND OPPORTUNITIES FOR TREATMENT

open access: yesРоссийский кардиологический журнал, 2017
The review focuses on cardiorenal syndrome developing in patients with chronic heart failure. The specifics of pathogenesis is discussed, as diagnostics and prognosis, with emphasis on the opportunities of modern biomarker strategy.
E. A. Medvedeva   +3 more
doaj   +1 more source

Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?

open access: yesLife, 2023
The pathologic triangle formed by chronic heart failure (HF), chronic kidney disease (CKD), and anemia carries high morbidity and mortality rates and decreases quality of life.
Oana Nicoleta Buliga-Finis   +6 more
doaj   +1 more source

Update on type 2 cardiorenal syndrome [PDF]

open access: yes, 2015
Department of Internal Medicine, Clinic of Cardiology, Clinic of Rheumatology and Nephrology, Nicolae Testemitsanu State University of Medicine and Pharmacy, Chisinau, the Republic of MoldovaBackground: Cardiorenal syndrome type 2 is an “umbrella” term ...
Sasu, B., Bivol, E., Grib, L.
core  

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo   +4 more
wiley   +1 more source

In reply: Cardiorenal syndrome

open access: yesCleveland Clinic Journal of Medicine, 2018
We thank Dr. Freda for his remarks and observations. Certainly, the clinical importance of this entity and the challenge it poses to clinicians cannot be overemphasized. We concur with the overall message and reply to his specific comments: We completely agree that clinical data-gathering is ...
Guramrinder S, Thind   +2 more
openaire   +2 more sources

Cardiorenal Syndrome, Hemodynamics, and Noninvasive Evaluation

open access: yes, 2017
Cardiorenal syndrome is a group of disorders resulting from the pathological interaction between the heart and the kidneys. The most accepted classification of cardiorenal syndrome differentiates the types based on the temporal sequence of organ ...
Ibrahim, Michel   +8 more
core   +1 more source

Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross‐Sectional Population‐Based Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Chronic kidney disease (CKD) is a common complication of Type 2 diabetes that frequently co‐occurs with cardiovascular disease. We aimed to characterise CKD in adults with Type 2 diabetes, quantify its prevalence across severity levels and examine pharmacological treatment patterns and healthcare utilisation.
Neora Alterman   +4 more
wiley   +1 more source

Cardiorenal syndrome-current understanding and future perspectives

open access: yes, 2014
Combined cardiac and renal dysfunction has gained considerable attention. Hypotheses about its pathogenesis have been formulated, albeit based on a relatively small body of experimental studies, and a clinical classification system has been proposed ...
Amir H. Danishwar   +7 more
core   +1 more source

Preeclampsia: a gestational cardiorenal syndrome [PDF]

open access: yes, 2019
It is generally accepted today that there are two different types of preeclampsia: an early-onset or placental type and a late-onset or maternal type. In the latent phase, the first one presents with a low output/high resistance circulation eventually ...
Thilaganathan, Basky   +5 more
core   +1 more source

The Effects of Combined Antihypertensive and Antidiabetic Therapies on Cardiovascular Outcomes: A Systematic Review and Meta‐Analysis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Hypertension and diabetes frequently coexist, yet the net clinical impact of intentionally combining antihypertensive (AHTN) and antidiabetic (ADA) therapies on cardiovascular (CV) outcomes is uncertain. Here we quantified the effects of AHTN and ADA co‐therapy on CV and blood pressure (BP)/heart rate (HR) outcomes.
Wan Chin Hsieh   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy